De novo drug design through artificial intelligence: an introduction

De novo drug design through artificial intelligence: an introduction

Developing new drugs is a complex and formidable challenge, intensified by rapidly evolving global health needs. De novo drug design is a promising strategy to accelerate and refine this process. The recent introduction of Generative Artificial Intelligence (AI) algorithms has brought new attention...

Full description

Bibliographic Details
Main Authors: Davide Crucitti, Carlos Pérez Míguez, José Ángel Díaz Arias, Diego Beltrán Fernandez Prada, Adrián Mosquera Orgueira
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Hematology
Subjects:
de novo
drug design
artificial intelligence
cheminformatics
machine learning
Online Access:https://www.frontiersin.org/articles/10.3389/frhem.2024.1305741/full

Internet

https://www.frontiersin.org/articles/10.3389/frhem.2024.1305741/full

Similar Items